KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Goodwill & Intangibles (2016 - 2025)

Emergent BioSolutions (EBS) has 16 years of Goodwill & Intangibles data on record, last reported at $469.0 million in Q2 2025.

  • For Q2 2025, Goodwill & Intangibles changed N/A year-over-year to $469.0 million; the TTM value through Jun 2025 reached $469.0 million, changed N/A, while the annual FY2024 figure was $501.5 million, 11.49% down from the prior year.
  • Goodwill & Intangibles reached $469.0 million in Q2 2025 per EBS's latest filing, down from $501.5 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $914.7 million in Q1 2021 and bottomed at $218.2 million in Q4 2022.
  • Average Goodwill & Intangibles over 5 years is $604.2 million, with a median of $587.8 million recorded in 2023.
  • Peak YoY movement for Goodwill & Intangibles: plummeted 73.69% in 2022, then skyrocketed 159.67% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $829.5 million in 2021, then crashed by 73.69% to $218.2 million in 2022, then surged by 159.67% to $566.6 million in 2023, then decreased by 11.49% to $501.5 million in 2024, then fell by 6.48% to $469.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $469.0 million in Q2 2025, $501.5 million in Q4 2024, and $566.6 million in Q4 2023.